共 104 条
[11]
Nazzaro P(2009)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 6237-673
[12]
Buonadonna AL(2014)Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients Pathology 46 604-154
[13]
Covelli C(2018)Is Cytoreductive surgery with Hyperthermic Intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the peritoneal surface oncology group international registry Ann Surg Oncol 25 667-737
[14]
Lettini T(2016)The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification J Thorac Oncol 11 142-59
[15]
Scattone A(2016)Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma Histopathology. 68 729-733
[16]
Serio G(2017)Reproducibility for histologic parameters in peritoneal mesothelioma Hum Pathol 67 54-15
[17]
Vimercati L(2017)BAP1 is altered by copy number loss, mutation, and/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas J Thorac Oncol 12 724-3308
[18]
Pennella A(2016)Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma Hum Pathol 51 9-538
[19]
Serio G(2005)P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma Clin Cancer Res 11 3303-1265
[20]
Pezzuto F(2010)CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival Mod Pathol 23 531-1923